AZƏRBAYCANDA GÖZÜN ƏLAVƏ APARATININ YENİTÖRƏMƏLƏRİNİN YAYILMASI XÜSUSİYYƏTLƏRİ

Xülasə

SUMMARY

Aim - to study the peculiarities of the spread of neoplasms of the adnexal apparatus of the eye in Azerbaijan.

Material and methods
For the period from 2009 to 2013, in stationary departments of the National Center for Ophthalmology, 360361
patients with various eye pathologies were examined and treated. Of these, 198 patients were identified neoplasms
of the eye and its adnexa, which amounted to 54,9 ± 3,9 per 100 thousand people with different pathologies.

Results
For the purpose of comparative analysis of neoplasms of the adnexa, 6 regions were conventionally selected:
Baku-Sumgayit, Greater Caucasus, Kura-Araks lowland, Lesser Caucasus, Lankaran, Middle Araks. Within
five years, an increase in the number of patients with neoplasms of the adnexa was found. A larger number of
patients accounted for the Baku-Sumgayit region, which amounted to 8,632 ± 0,846 per 1 million population.
The second place is occupied by the Kura-Intermountain region (5,779 ± 0,792 per 1 million population). The
statistically significant difference between the indicators of Baku city was p <0,001, p <0,05, p <0,001, p <0,001,
p <0,001. When studying the gender number of patients who applied with this pathology for 1 million people over
5 years, there was an insignificant difference for different years. However, the final result among men per 1 million
population was 4,11± 0,43, among women -4,57± 0,45.
From 2009 to 2013, there was a progression in the frequency of circulation of patients with neoplasms of the
adnexa. At the same time, a dynamic increase in the rates of benign and malignant tumors was recorded. So, in
2013, these figures, respectively, per 100 thousand calls amounted to 45,27 ± 8,27 and 36,22 ± 7,39.

Conclusion
In terms of frequency of circulation, benign neoplasms of the adnexa are most common compared with
malignant tumors (62,6 ± 3,4% and 37,4 ± 3,4%, p <0,001, respectively). It was revealed that the Baku-Sumgayit
zone leads in the frequency of negotiability of patients with tumors of different origin (52,5 ± 3,5%, p <0,001).